Sanofi India Limited

BSE:500674 Stock Report

Market Cap: ₹141.7b

Sanofi India Past Earnings Performance

Past criteria checks 3/6

Sanofi India has been growing earnings at an average annual rate of 4.7%, while the Pharmaceuticals industry saw earnings growing at 13.5% annually. Revenues have been declining at an average rate of 1.9% per year. Sanofi India's return on equity is 77.5%, and it has net margins of 18.8%.

Key information

4.7%

Earnings growth rate

4.7%

EPS growth rate

Pharmaceuticals Industry Growth17.5%
Revenue growth rate-1.9%
Return on equity77.5%
Net Margin18.8%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Sanofi India makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BSE:500674 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2428,2255,3043,9080
30 Jun 2427,8935,2884,0550
31 Mar 2428,4705,4914,1320
31 Dec 2328,5116,0294,1260
30 Sep 2328,2915,9614,1780
30 Jun 2328,0645,7514,2190
31 Mar 2327,9965,7264,3230
31 Dec 2227,7016,2064,4140
30 Sep 2227,8615,8014,6030
30 Jun 2228,4879,7904,7040
31 Mar 2229,38510,3694,7830
31 Dec 2129,5669,4444,8360
30 Sep 2129,8909,7704,8850
30 Jun 2129,2115,8014,9070
31 Mar 2128,4255,3815,0240
31 Dec 2029,0194,7765,1640
30 Sep 2030,0794,5195,6350
30 Jun 2031,0044,4565,7090
31 Mar 2031,3784,0674,6640
31 Dec 1930,7064,1425,4460
30 Sep 1929,7073,9625,2690
30 Jun 1929,3543,8885,1450
31 Mar 1928,7043,9105,0080
31 Dec 1827,7083,8064,9280
30 Sep 1826,8703,7734,7730
30 Jun 1826,1073,7444,6940
31 Mar 1825,2843,4854,6390
31 Dec 1724,6363,2604,5760
30 Sep 1723,7472,9534,4260
30 Jun 1723,4542,6194,3930
31 Mar 1723,6502,7444,2880
31 Dec 1623,6683,0424,2210
30 Sep 1623,4522,9894,2420
30 Jun 1623,0682,9094,1180
31 Mar 1622,4862,6993,3820
31 Dec 1521,9312,3774,0000
30 Sep 1521,3632,1116,2310
30 Jun 1520,6542,0056,1360
31 Mar 1520,2151,9386,0520
31 Dec 1419,7751,9713,5550
30 Sep 1419,5392,3845,5820
30 Jun 1419,3642,5345,4710
31 Mar 1418,6572,4715,3890

Quality Earnings: 500674 has high quality earnings.

Growing Profit Margin: 500674's current net profit margins (18.8%) are lower than last year (21.1%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 500674's earnings have grown by 4.7% per year over the past 5 years.

Accelerating Growth: 500674's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 500674 had negative earnings growth (-11%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (20.5%).

Return on Equity

High ROE: 500674's Return on Equity (77.5%) is considered outstanding.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/31 12:35
End of Day Share Price 2024/12/31 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sanofi India Limited is covered by 14 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sarabjit NangraAngel Broking Private Limited
Rohit BhatBatlivala & Karani Securities India Pvt. Ltd.
Ranjit KapadiaCentrum Broking Limited